These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 8222910)

  • 1. Safety and immunogenicity of live attenuated hepatitis A virus vaccine (H2 strain) in humans.
    Ran LA; Wang DZ; Duan QY; Yan TY; Liu QL; Luo YG; Yang DZ; Yang DF; Xiao Z; Xie QJ
    Chin Med J (Engl); 1993 Aug; 106(8):604-7. PubMed ID: 8222910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Immunological effects of live attenuated hepatitis A vaccine].
    Cheng NL
    Zhonghua Yi Xue Za Zhi; 1992 Oct; 72(10):581-3, 638. PubMed ID: 1338501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Immunogenicity and efficacy trials of live attenuated hepatitis A vaccines].
    Xu Z; Li R; Meng Z
    Zhonghua Yi Xue Za Zhi; 1998 Apr; 78(4):254-6. PubMed ID: 10923477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Observation of live, attenuated hepatitis A vaccines in humans].
    Hu MD
    Zhonghua Yu Fang Yi Xue Za Zhi; 1993 Mar; 27(2):65-8. PubMed ID: 8394801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Horizontal transmission of live attenuated hepatitis A vaccine virus].
    Huang X; Cao Y; Tan S
    Zhonghua Yi Xue Za Zhi; 2001 Apr; 81(8):465-7. PubMed ID: 11798919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Safety observation of attenuated live hepatitis B vaccine (H2 strain) in humans].
    Zhang S
    Zhonghua Yi Xue Za Zhi; 1990 Dec; 70(12):682-4, 48. PubMed ID: 1963372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Persistent efficacy of live attenuated hepatitis A vaccine (H2-strain) after a mass vaccination program.
    Zhuang FC; Qian W; Mao ZA; Gong YP; Jiang Q; Jiang LM; Chen NL; Chai SA; Mao JS
    Chin Med J (Engl); 2005 Nov; 118(22):1851-6. PubMed ID: 16313838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and immunogenicity of a live attenuated hepatitis A virus vaccine in seronegative volunteers.
    Midthun K; Ellerbeck E; Gershman K; Calandra G; Krah D; McCaughtry M; Nalin D; Provost P
    J Infect Dis; 1991 Apr; 163(4):735-9. PubMed ID: 1849160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical trial to evaluate immunogenicity and safety of inactivated hepatitis A vaccination starting at 2-month-old children.
    Kanra G; Yalçin SS; Ceyhan M; Yurdakök K
    Turk J Pediatr; 2000; 42(2):105-8. PubMed ID: 10936974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Studies on re-immunization with live attenuated hepatitis A vaccine].
    Liu Y; Xu Z; Ouyang P
    Zhonghua Yu Fang Yi Xue Za Zhi; 1998 May; 32(3):162-4. PubMed ID: 10322791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunogenicity and safety of an inactivated hepatitis A vaccine in Taiwanese adults and children.
    Lee CY; Huang LM; Lee PI; Chiu HH; Dumas R; Milcamps B; Lin W
    Southeast Asian J Trop Med Public Health; 2000 Mar; 31(1):29-36. PubMed ID: 11023061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Experimental in vivo passage of H2 strain of live attenuated vaccine of hepatitis A in common marmosets].
    Huang X; Lian Y; Wang Q
    Zhonghua Yu Fang Yi Xue Za Zhi; 1997 Sep; 31(5):260-2. PubMed ID: 9812599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The trial preparation of attenuated live hepatitis A vaccine].
    Dong DX
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1989 Feb; 11(1):1-6. PubMed ID: 2548744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparison of immunology effects between live attenuated hepatitis A vaccine and inactivated hepatitis A vaccine].
    Wang X; Meng Z; Li R
    Zhonghua Yi Xue Za Zhi; 2000 Jun; 80(6):422-4. PubMed ID: 11798797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hereditable characteristics of attenuated live hepatitis A virus H2 strain].
    Chai SA
    Zhonghua Yi Xue Za Zhi; 1993 Jun; 73(6):335-7, 380. PubMed ID: 8258101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Safety and immunogenicity of Bilive combined hepatitis A and B vaccine].
    Zhao YL; Chen YG; Li J; Han GX; Tian C; Liang JL; Li G; Wang ZG; Zhu YG; Tian ZN; Zhang HY; Wan ZJ; Liang ZL; Bi SL
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Jun; 25(6):470-3. PubMed ID: 15231119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term immunogenicity after single and booster dose of a live attenuated hepatitis A vaccine: results from 8-year follow-up.
    Wang XY; Xu ZY; Ma JC; von Seidlein L; Zhang Y; Hao ZY; Han OP; Zhang YL; Tian MY; Ouyang PY; Zhang ZY; Han CQ; Xing ZC; Chen JC
    Vaccine; 2007 Jan; 25(3):446-9. PubMed ID: 16949710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunogenicity and safety of live attenuated hepatitis A vaccine: a multicentric study.
    Faridi MM; Shah N; Ghosh TK; Sankaranarayanan VS; Arankalle V; Aggarwal A; Sathiyasekaran M; Bhattacharya N; Vasanthi T; Chatterjee S; Choudhury J; Mitra M
    Indian Pediatr; 2009 Jan; 46(1):29-34. PubMed ID: 19179715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The immunological effects of three doses of a live attenuated hepatitis A vaccine (H2 strain) in 8 years].
    Liu HF; Zhang XJ; Zhang JL; Hao ZY; Zhang ZY; Ma JC; Chen JC; Chu J; Wang XY; Xu ZY
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2009 Jun; 23(3):180-1. PubMed ID: 20104771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune responses of anti-HAV in children vaccinated with live attenuated and inactivated hepatitis A vaccines.
    Wang XY; Xu Z; Yao X; Tian M; Zhou L; He L; Wen Y
    Vaccine; 2004 May; 22(15-16):1941-5. PubMed ID: 15121306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.